Copyright
©The Author(s) 2021.
World J Clin Cases. Mar 6, 2021; 9(7): 1532-1542
Published online Mar 6, 2021. doi: 10.12998/wjcc.v9.i7.1532
Published online Mar 6, 2021. doi: 10.12998/wjcc.v9.i7.1532
Clinical factor | Hepatitis cirrhosis | Alcoholic cirrhosis | Autoimmune cirrhosis | Statistic | P value |
Gender (n) | χ2 = 3.43 | 0.18 | |||
Male | 46 | 42 | 31 | ||
Female | 25 | 25 | 31 | ||
Age (yr, mean ± SD) | 55.5 ± 8.7 | 54.7 ± 8.5 | 55.3 ± 9.6 | F = 0.15 | 0.87 |
Child-Pugh Classification | χ2 = 3.19 | 0.53 | |||
A | 32 | 25 | 19 | ||
B | 34 | 35 | 37 | ||
C | 5 | 7 | 6 | ||
Child-Pugh score | 7.25 ± 1.54 | 7.55 ± 1.45 | 7.48 ± 1.29 | F = 0.82 | 0.44 |
MELD score | 10.24 ± 3.52 | 9.67 ± 2.90 | 10.47 ± 2.97 | F = 1.11 | 0.33 |
Prothrombin time (s) | 14.59 ± 2.79 | 14.98 ± 2.46 | 14.74 ± 2.92 | F = 0.36 | 0.69 |
ALT (IU/L) | 35.28 ± 16.40 | 37.75 ± 12.17 | 36.95 ± 10.82 | F = 0.42 | 0.67 |
AST (IU/L) | 48.87 ± 24.43 | 50.13 ± 23.10 | 50. 75 ± 24.34 | F = 0.06 | 0.94 |
Albumin (g/L) | 35.09 ± 6.33 | 34.14 ± 4.52 | 34.23 ± 4.44 | F = 0.69 | 0.50 |
Total bilirubin (μmol/L) | 33.53 ± 12.99 | 32.75 ± 14.88 | 32.47 ± 16.84 | F = 0.04 | 0.96 |
PPG before TIPS (mmHg) | 24.58 ± 4.79 | 25.45 ± 5.16 | 25.27 ± 5.65 | F = 1.78 | 0.17 |
PPG after TIPS (mmHg) | 9.94 ± 2.55 | 10.22 ± 3.07 | 10.01 ± 2.65 | F = 0.22 | 0.80 |
Deaths in 24 mo, n (%) | 8 (11.3) | 12 (17.9) | 9 (14.5) | χ2 = 1.23 | 0.54 |
HE in 24 mo, n (%) | 15 (21.1) | 17 (25.4) | 18 (29.0) | χ2 = 1.11 | 0.57 |
Baseline | 1 wk | 1 mo | 3 mo | 6 mo | 12 mo | 24 mo | |
Hepatitis cirrhosis (n) | 18/45/8 (71) | 14/46/11 (71) | 10/52/9 (71) | 9/53/9 (71) | 16/49/5 (70) | 23/42/3 (68) | 34/28/1 (63) |
Child-Pugh A/B/C (%) | 25.4/63.4/11.3 | 19.7/64.8/15.5 | 14.1/73.2/12.7 | 12.7/74.6/12.7 | 22.9/70.0/7.1 | 33.8/61.8/4.4 | 54.0/44.4/1.6 |
Alcoholic cirrhosis (n) | 14/46/7 (67) | 7/52/8 (67) | 8/51/8 (67) | 6/49/12 (67) | 12/45/8 (65) | 15/41/5 (61) | 13/37/5 (55) |
Child-Pugh A/B/C (%) | 20.8/68.7/10.4 | 10.4/77.6/11.9 | 11.9/76.1/12.0 | 8.9/73.2/17.9 | 18.5/69.2/12.3 | 24.6/67.2/8.2 | 23.6/67.3/9.1 |
Autoimmune cirrhosis (n) | 12/45/5 (62) | 7/49/6 (62) | 10/43/8(61) | 8/41/12 (61) | 11/43/6 (60) | 13/43/2 (58) | 14/35/4 (53) |
Child-Pugh A/B/C (%) | 19.4/72.6/8.1 | 11.3/79.0/9.7 | 16.4/70.5/13.1 | 13.1/67.2/19.7 | 18.3/71.7/10.0 | 22.4/74.1/3.5 | 26.4/66.1/7.5 |
- Citation: Yao X, Zhou H, Huang S, Tang SH, Qin JP. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis. World J Clin Cases 2021; 9(7): 1532-1542
- URL: https://www.wjgnet.com/2307-8960/full/v9/i7/1532.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i7.1532